Raymond James Financial Inc Precigen, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 12,805 shares of PGEN stock, worth $19,591. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,805Holding current value
$19,591% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PGEN
# of Institutions
142Shares Held
161MCall Options Held
232KPut Options Held
69K-
Third Security, LLC83.5MShares$128 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.9MShares$27.4 Million0.92% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.9MShares$16.6 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$15.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$12.7 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $318M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...